| Autor: |
Gorenek B; Cardiology Department, Eskisehir Osmangazi University, Turkey., Halvorsen S; Department of Cardiology, Oslo University Hospital Ulleval, Norway., Kudaiberdieva G; Adana, Turkey.; Scientific Research Institute of Heart Surgery and Organ Transplantation, Kyrgyzstan., Bueno H; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Spain., Van Gelder IC; University Medical Center Groningen, University of Groningen, The Netherlands., Lettino M; Cardiovascular Department, Humanitas Research Hospital, Italy., Marin F; Hospital Clínico, Universitario Virgen de la Arrixaca, Spain., Masip J; Cardiology Department, Hospital Sanitas CIMA, University of Barcelona, Spain., Mueller C; Cardiovascular Research Institute, University Hospital of Basel, Switzerland., Okutucu S; Department of Cardiology, Memorial Ankara Hospital, Turkey., Poess J; Department of Internal Medicine/Cardiology, Heart Center Leipzig-University Hospital, Germany., Potpara TS; School of Medicine, Belgrade University, Serbia.; Cardiology Clinic, Clinical Center of Serbia, Serbia., Price S; Royal Brompton Hospital, UK., Lip GYH; Liverpool Centre for Cardiovascular Science, University of Liverpool, UK.; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Denmark. |
| Abstrakt: |
Atrial fibrillation and acute heart failure frequently co-exist and can exacerbate each other. Their combination leads to increased morbidity and mortality. However, the prevalence and significance, as well as the treatment, of atrial fibrillation in acute heart failure are not well studied. Management of atrial fibrillation in acute heart failure requires a multidisciplinary team approach. Treatment of underlying disease(s), identification and treatment of potentially correctable causes and precipitating factors and anticoagulation are crucial. In this article, current evidence on atrial fibrillation in the setting of acute heart failure is summarised. The recommendations on management of atrial fibrillation in the prehospital stage, the treatment of reversible causes, when and how to use rate or rhythm control, maintenance of sinus rhythm, catheter ablation and pacing, anticoagulation, as well as measures on prevention of atrial fibrillation are provided. |
